A share price of Procept BioRobotics Corp [PRCT] is currently trading at $99.27, up 1.52%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PRCT shares have gain 6.09% over the last week, with a monthly amount glided 9.09%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on November 14, 2024, when Jefferies initiated its Hold rating and assigned the stock a price target of $95. Previously, Piper Sandler started tracking the stock with Overweight rating on August 11, 2023, and set its price target to $42. On May 31, 2023, William Blair initiated with a Outperform rating. BTIG Research started tracking the stock assigning a Neutral rating. Truist initiated its recommendation with a Buy and recommended $58 as its price target on October 25, 2022. Wells Fargo started tracking with a Overweight rating for this stock on September 02, 2022, and assigned it a price target of $49. In a note dated July 15, 2022, KeyBanc Capital Markets initiated an Overweight rating and provided a target price of $47 on this stock.
Procept BioRobotics Corp experienced fluctuations in its stock price throughout the past year between $33.45 and $103.81. Currently, Wall Street analysts expect the stock to reach $76.33 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $99.27 at the most recent close of the market. An investor can expect a potential drop of -23.11% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
Trailing Twelve Months sales for Procept BioRobotics Corp [NASDAQ:PRCT] were 199.84M which represents 66.29% growth. Gross Profit Margin for this corporation currently stands at 0.56% with Operating Profit Margin at -0.53%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.39 and Total Capital is -0.33. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 96.92 points at the first support level, and at 94.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 100.74, and for the 2nd resistance point, it is at 102.21.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Procept BioRobotics Corp [NASDAQ:PRCT] is 6.02. Further, the Quick Ratio stands at 5.07, while the Cash Ratio is 3.67. Considering the valuation of this stock, the price to sales ratio is 27.02, the price to book ratio is 21.46.
Transactions by insiders
Recent insider trading involved Zadno Reza, President, CEO, that happened on Nov 20 ’24 when 26420.0 shares were sold. Director, REZA ZADNO completed a deal on Nov 20 ’24 to buy 26420.0 shares. Meanwhile, President, CEO Zadno Reza sold 26420.0 shares on Nov 13 ’24.
